20 Sep 2019 --- Collagen peptides can improve overall bone health by simultaneously targeting bone formation and bone resorption. This is according to a Rousselot and French National Institute for Agronomic Research (INRA)-endorsed study, which examined the effects of its Peptan brand of collagen peptides on bone metabolism. Via a “pioneering” clinical screening approach developed by the INRA the study, published in Nutrients, the findings indicate that Peptan’s collagen peptides directly target and modulate the function of bone-remodeling cells. This provides further evidence that the benefits of bioactive collagen peptides go beyond simple protein supplementation and are an effective nutritional intervention to support bone health.